Pharmaceutical Sciences

M.S., Ph.D. (Pharmaceutical Sciences)

401.874.2789

Faculty

Medicinal Chemistry and Pharmacognosy: Professors Cho Laplante and Rowley; Associate Professors King and Seeram; Assistant Professors Li and Trzoss; Professor Emeritus Shimizu.

Pharmaceutics and Pharmacokinetics: Professors Akhlaghi Kislalioglu, Lausier, and Rosenbaum; Assistant Professors Lu  and Worthen; Professors Emeriti Needham and Zia.

Pharmacoepidemiology and Pharmacoeconomics: Professors  Kogut, Laplante, Larrat, Quilliam, and Temkin;  Assistant Professor Caffrey; Clinical Associate Professor Marcoux.

Pharmacology and Toxicology:  Professors Chichester Shaikh, Yan, and Zawia; Associate Professors Deng, King, Kovoor;  Professor Emeritus Rodgers and Swonger.

Other Graduate Faculty: Professors Barbour, Dufresne, Hume, Owens, and Taveira; Clinical Professors Bratberg and MacDonnell; Associate Professors Cohen and Goren;

Specializations

Medicinal Chemistry and Pharmacognosy: Molecular mechanisms of chemical carcinogenesis; mutation and repair; combinatorial chemistry; solid-phase peptide synthesis; screening, isolation, and structure elucidation of physiologically-active natural products; biosynthesis of microbial and plant natural products; herbal medicine; bioinformatics.

Pharmaceutics and Pharmacokinetics: Design, development, production, evaluation, and regulatory approval of pharmaceutical and self-care products as well as pharmacokinetic and pharmacodynamic studies using virtual, clinical, and preclinical data, often with an emphasis on population approaches.

Pharmacoepidemiology and Pharmacoeconomics: Health and economic outcomes research pertaining to pharmacotherapy as used in human populations. Specializations include medication adherence, decision and cost-effectiveness analyses, post-marketing surveillance, epidemiologic methods, and quality improvement and measurement.

Pharmacology and Toxicology: Mechanisms involved in disease states and their pharmacological intervention, and mechanisms of toxicity of environmental agents. Ongoing topics include the effects of hormonal imbalances on cardiac function and metabolism in hypertension, biomarkers and treatment of arthritis, developmental neurotoxicity of environmental agents, hepatotoxicity and nephrotoxicity of heavy metals, pharmacogenomics, drug interactions, drug metabolism and drug transporters, and the development of inhibitors to cell signaling events.

Master of Science

Admission requirements: GRE and Pharm.D. or bachelor’s degree in pharmacy, chemistry, biological sciences, or allied sciences; TOEFL or IELTS (waived for applicants from countries where English is the primary language).

Program requirements: Successful completion of 30 credits of graduate study, including PHC 502, 2 seminar credits(PHC 693/694), PHC 599, and a thesis.

For specialization in medicinal chemistry and pharmacognosy: Three credits of BPS 530, BPS 535, or BPS 587; Six to seven credits of BPS 525, BCH 581, BCH 582, CHM 427, CHM 520, CHM 521, or CHM 522; Six to nine credits of PHC 599; Four to seven elective credits in consultation with student’s major professor.

For specialization in pharmaceutics and pharmacokinetics: STA 409 or 411 or equivalent; Six to nine credits of 500- or 600-level BPS courses; Six to nine credits of PHC 599; Remaining elective credits at the 500/600 level in consultation with student’s major professor.

For specialization in pharmacoepidemiology and pharmacoeconomics: PHP 540, and PHP 550 or PHP 580; Six credits of STA 409, 411, or 412; Six to nine credits of PHC 599; Four to nine elective credits in consultation with student’s major professor.

For specialization in pharmacology and toxicology: At least 9 credits of BPS 587, BPS 546, BPS 641, BPS 530, BPS 535, BCH 581, or PHC 520; Three credits of BPS 422, BPS 521, BPS 525, BCH 582, or BCH 642; Three credits of BPS 503, BPS 533 or PHP 540; Six to nine credits of PHC 599; Remaining elective credits at the 500/600 level in consultation with student’s major professor.

Doctor of Philosophy

Admission requirements: GRE and master’s degree in pharmacy, chemistry, biological sciences, or allied sciences, or bachelor’s degree in one of these areas with evidence of superior ability; TOEFL or IELTS (waived for applicants from countries where English is the primary language). A qualifying examination is required for candidates accepted without the master’s degree. This requirement is satisfied by completing, with a grade of B or better, PHC 502 and six credits from BPS 530, BPS 535, BPS 546, BPS 587, BPS 641, PHP 540, PHP 550 or PHP 580 within the first two academic semesters.

Program requirements: Successful completion of 72 credits of graduate study, including PHC 502, PHC 693/694 (3 credits), PHC 699, a qualifying exam, written and oral comprehensive examination, and a dissertation. Students are expected to attend and participate in the departmental seminars during their entire tenure in the Ph.D. program, for a maximum of three credits assigned to the core credit requirement.

For specialization in medicinal chemistry and pharmacognosy: Six credits of BPS 530, BPS 535, or BPS 587; Nine to ten credits of BPS 525, BCH 581, BCH 582, CHM 427, CHM 520, CHM 521, or CHM 522; Additional course credits at the 500/600 level (including up to 3 credits of PHC 520) must be selected in conjunction with major professor and/or doctoral committee.   All students are required to complete a minimum of 30 credit hours in courses other than those deemed to carry research, independent study, or directed study credits.

For specialization in pharmaceutics and pharmacokinetics: Four credits of PHC 693/694, STA 411 or equivalent, a 500-level statistics course, BPS 503 and BPS 555. Additional course credits must be selected in conjunction with major professor and/or doctoral committee. All students are required to complete a minimum of 30 credit hours in courses other than those deemed to carry research, independent study, or directed study credits.. Pharmacokinetics students must successfully complete BPS 530 and BPS 670.

For specialization in pharmacoepidemiology and pharmacoeconomics: PHP 540, PHP 550, and PHP 580 or PHP 640; Six credits of STA 409, 411, or 412; Six credits of STA 502, PSY 533, STA 535, STA 536, STA 541, or STA 542; Thirty-six credits from either PHP 697, PHP 698 or PHC 699, or additional 500/600 level elective courses determined in consultation with the major professor; Elective credits in consultation with student’s major professor. Tutorials may be arranged in areas of special interest to the student, in consultation with student’s major professor.

For specialization in pharmacology and toxicology: BPS 587, BPS 546, BPS 530, BPS 535, BPS 641, BCH 581 and PHC520; Six credits of BPS 422, BPS 521, BPS 525, BCH 582, or BCH 642; Three credits of BPS 503, BPS 533, and PHP 540.

Students transferring 30 credits from M.S. degree:  Students transferring 30 credits from an M.S. degree program must complete a minimum of 12 course credits, excluding PHC 693/694, PHC 599 and special problems courses, selected in consultation with the major advisor.

Joint Doctor of Pharmacy/Master of Business Administration Program

The University of Rhode Island Colleges of Pharmacy and Business Administration offer a joint program that allows students the opportunity to develop management and administrative skills as they study for the Doctor of Pharmacy (Pharm.D.) degree. This program qualifies individuals to assume leadership and management roles in the health care industry. A unique combination of management and pharmacy coursework, coupled with innovative practicum experiences, provides students with a knowledge base of theoretical and applied information. The joint program requires the student to complete a total of 226 credits.

Students enrolled in the Doctor of Pharmacy program are eligible to apply for admission to the joint program after their second professional year (by July 15). The following are required at that time: GMAT, statement of purpose, résumé, two letters of recommendation, and TOEFL (waived for applicants from countries where English is the primary language).

Joint Doctor of Pharmacy/Master of Science Degree Program

The University of Rhode Island College of Pharmacy offers a joint program that allows students the opportunity to pursue the Master of Science degree while studying for the Doctor of Pharmacy degree. Students may elect to study in any one of the four specialization areas described in the graduate program: medicinal chemistry and pharmacognosy, pharmaceutics and pharmacokinetics, pharmacoepidemiology and pharmacoeconomics, or pharmacology and toxicology.

This program is designed for highly qualified and motivated students who are interested in simultaneously pursuing the Pharm.D. and M.S. degrees. Students are expected to complete the Pharm.D. program as described in this catalog. In addition, students must complete all additional credits required for the M.S. degree, complete a research project, and write and defend a thesis. It is expected that the motivated student will be enrolled during the summer sessions after the fourth, fifth, and sixth years with the objective of completing both degrees at the same time or in one additional semester.

Students enrolled in the Doctor of Pharmacy program are eligible to apply for admission to this joint degree program in the second semester of their first professional year (by May 1). The following are required at that time: statement of purpose, résumé, and two letters of recommendation.